A comparison of ciprofloxacin, norfloxacin, ofloxacin, azithromycin and cefixime examined by observational cohort studies

British Journal of Clinical Pharmacology

Volumn 41, Issue 4, 1996, Pages 277-284

  Wilton, L V ^a   Pearce, G L ^a   Mann, R D ^a  

^a DRUG SAFETY RESEARCH UNIT   (United Kingdom)

Author keywords

Azithromycin; Cefixime; Norfloxacin; Observational cohort studies; Ofloxacin; Pharmacovigilance; Prescription event monitoring ciprofloxacin

Indexed keywords

AZITHROMYCIN; CIPROFLOXACIN; NORFLOXACIN; OFLOXACIN;

ABDOMINAL PAIN; ARTICLE; BACTERIAL INFECTION; DIARRHEA; HEADACHE; HUMAN; MALAISE; MIGRAINE; NAUSEA; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; VERTIGO; VOMITING;

EID: 0029867403     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1996.03013.x     Document Type: Article

References (13)

1. Meyboom RHB, Olsson S, Kuol A, Dekens-Kouter JAM, de Koning GHP. Achilles tendinitis induced by pefloxacin and other fluoroquinolone derivatives. Pharmaco-epidemiology and Drug Safety, 1994; 3: 185-189.
2. British National Formulary, 1995; 30: 252.
3. Inman WHW. An introduction to Prescription-Event Monitoring. In Adverse Drug Reactions. ed Mann RD, Carnforth UK.: Parthenon Publishing. 1987: 177-199.
4. Mann RD. Epidemiologic Study Systems: Prescription-Event Monitoring in the UK. Southampton Med J 1994; 10: 12-17.
5. Rawson NSB, Pearce GL, Inman WHW. Prescription-Event Monitoring: Methodology and recent progress. J Clin Epidemiol 1990; 43: 509-22.
6. Johnson NL, Kotz S. Poisson Distribution. In Discrete Distribution, Boston: Houghton Mifflin Company, 1969: 87-121.
7. Kubota K, Kubota N, Pearce GL, Prescott P, Mann RD. Signalling drug-induced rash with 36 drugs recently marketed in the United Kingdom and studied by Prescription-Event Monitoring. Int J Clin Pharmacol Ther 1995; 33: 219-225.
8. Andrew JE, Prescott P, Smith TMF, Inman WHW, Kubota K. Testing for Adverse Reactions Using Prescription-Event Monitoring. Stat Med 1996; (in press).
9. Council for International Organizations of Medicinal Sciences (CIOMS), World Health Organization (WHO). International Ethical Guidelines for Biomedical Research Involving Human Subjects. Geneva: 1993.
10. Rawlins MD, Thompson JW. Pathogenesis of adverse drug reactions. In Textbook of adverse drug reactions. ed Davis DM, Oxford University Press 1977: 10-31.
11. Anon. Abbott withdraws temafloxacin. Scrip 1992; No. 1726: 25.
12. Finney DJ. The design and logic of a monitor of drug use. J Chron Dis 1965; 18: 77.
13. Rawlins MD, Jefferys DB. Study of United Kingdom Product Licence Applications containing new active substances, 1987-9. Br Med J 1991; 302: 223-225.